Biohaven (BHVN) Accumulated Expenses (2021 - 2026)

Biohaven has disclosed Accumulated Expenses across 6 years of filings, most recently posting $41.7 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $41.7 million, down 26.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.7 million (down 26.37% YoY), and the FY2025 annual result was $104.3 million, up 102.56% from the prior year.
• Accumulated Expenses came in at $41.7 million for Q1 2026 at Biohaven, down from $104.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $104.3 million in Q4 2025 to a low of $23.7 million in Q3 2022.
• The 5-year median for Accumulated Expenses is $51.5 million (2024), against an average of $54.1 million.
• Across the five-year window, Accumulated Expenses jumped 122.05% in 2023 and declined 26.37% in 2026, its largest moves.
• Biohaven's Accumulated Expenses stood at $44.1 million in 2022, then slipped by 9.66% to $39.8 million in 2023, then advanced by 29.21% to $51.5 million in 2024, then soared by 102.56% to $104.3 million in 2025, then plunged by 60.06% to $41.7 million in 2026.
• The last three Accumulated Expenses figures came in at $41.7 million (Q1 2026), $104.3 million (Q4 2025), and $73.5 million (Q3 2025), per Business Quant data.